Ulcerative Colitis
Ulcerative colitis (UC) is a chronic inflammatory condition of the colon that causes ulcers in the lining of the intestines, leading to symptoms such as abdominal pain, diarrhea, and rectal bleeding.
Etrasimod for Adolescents with Ulcerative Colitis
We are studying whether etrasimod can help adolescents aged 12 to 17 with moderately to severely active ulcerative colitis achieve remission. The trial will also look at the safety and how the body processes the medication.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have moderately to severely active ulcerative colitis (UC)?
- Do you have severe extensive colitis?
- Have you been diagnosed with Crohn’s disease or indeterminate colitis?
- Do you have a history of a fistula related to Crohn’s disease?
- Have you been diagnosed with microscopic colitis, ischemic colitis, or infectious colitis?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Gemeinnützige Salzburger Landes- Kliniken Betriebsgesellschaft mbH
Department of Pediatrics and Adolescent Medicine
Salzburg, Austria
UZ Leuven
Pediatric Gastroenterology at UZ Leuven
Heverlee, Belgium
Uniwersytecki Szpital Dzieciecy W Krakowie
Klinika Pediatrii, Gastroenterologii i Żywienia
Grzegórzki, Poland
Sponsor: Arena Pharmaceuticals Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.